# Episode 234 - Veoza & Lynkuet: The New Non-Hormonal Drugs for Hot Flushes After Cancer

Page: https://stenobird.com/podcast/the-menopause-and-cancer-podcast-5554044/episode-234-veoza-lynkuet-the-new-non-hormonal-drugs-for-hot-flushes-after-cancer
Text version: https://stenobird.com/podcast/the-menopause-and-cancer-podcast-5554044/episode-234-veoza-lynkuet-the-new-non-hormonal-drugs-for-hot-flushes-after-cancer.md
Podcast: [Navigating Menopause After Cancer](https://stenobird.com/podcast/the-menopause-and-cancer-podcast-5554044)
Published: 2026-09-09T01:30:00+00:00
Episode link: https://menopauseandcancer.org/podcast/
Audio file: https://episodes.captivate.fm/episode/5b302ad3-492c-4b5b-843e-ece483f11d1e.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-menopause-and-cancer-podcast-5554044/episodes/episode-234-veoza-lynkuet-the-new-non-hormonal-drugs-for-hot-flushes-after-cancer
Duration seconds: 2582

## Resource

“Night sweats. I cannot go on like this. What are people taking who can’t take HRT?” That was a recent post in our community and the replies came flooding in. Venlafaxine. Oxybutynin. Acupuncture. HRT. Lifestyle changes. So many people trying different things to manage debilitating hot flushes and night sweats after cancer. But increasingly, two new names are appearing in these conversations: fezolinetant (Veoza) and elinzanetant (Lynkuet). These newer non-hormonal medicines have been specifically developed to treat menopausal hot flushes and night sweats. But what are they? How do they work? And, crucially for our community, can you take them after cancer? I’m joined once again by the wonderful Dr Zoe Schaedel, NHS GP, menopause specialist and sleep expert, to give us a practical roadmap. We discuss: How fezolinetant and elinzanetant work and why they're different from some of the older non-hormonal options What we currently know about their use following different cancers Side effects, contraindications and the concerns you've perhaps heard about How to actually access them Why access can vary across the NHS What your local formulary and its “traffic light” classification can tell you Whether your GP can prescribe or whether you may need a menopause specialist or oncologist And for our listeners outside the UK, we also talk about some of the barriers to accessing these medicines elsewhere, including the frustrating issue of insurance coverage in the US. We’ve been following this story for a while… Way back in Episode 46 , I spoke to Professor Waljit Dhillo, one of the researchers behind this new approach to treating hot flushes. At the time, these medicines felt like an exciting glimpse into the future. Well, the future is here. People in our community are now taking…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-menopause-and-cancer-podcast-5554044/episodes/episode-234-veoza-lynkuet-the-new-non-hormonal-drugs-for-hot-flushes-after-cancer/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-menopause-and-cancer-podcast-5554044/episode-234-veoza-lynkuet-the-new-non-hormonal-drugs-for-hot-flushes-after-cancer.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.